1. A new recombinant rabies virus expressing a green fluorescent protein: A novel and fast approach to quantify virus neutralizing antibodies. (May 2019) Authors: Qin, Shuyun; Volokhov, Dmitriy; Rodionova, Elvira; Wirblich, Christoph; Schnell, Matthias J.; Chizhikov, Vladimir; Dabrazhynetskaya, Alena Journal: Biologicals Issue: Volume 59(2019) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever. Issue 1 (December 2018) Authors: Abreu-Mota, Tiago; Hagen, Katie; Cooper, Kurt; Jahrling, Peter; Tan, Gene; Wirblich, Christoph; Johnson, Reed; Schnell, Matthias Journal: Nature communications Issue: Volume 9:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tetravalent Rabies-Vectored Filovirus and Lassa Fever Vaccine Induces Long-term Immunity in Nonhuman Primates. (9th January 2021) Authors: Kurup, Drishya; Fisher, Christine R; Scher, Gabrielle; Yankowski, Catherine; Testa, AnnaMarie; Keshwara, Rohan; Abreu-Mota, Tiago; Lambert, Rachael; Ferguson, Melissa; Rinaldi, William; Ruiz, Leonard; Wirblich, Christoph; Schnell, Matthias J Journal: Journal of infectious diseases Issue: Volume 224:Number 6(2021) Page Start: 995 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗